Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
6.50
+0.13 (2.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Savara Market Cap
Savara has a market cap or net worth of $1.57 billion as of December 5, 2025. Its market cap has increased by 208.78% in one year.
Market Cap
1.57B
Enterprise Value
1.47B
1-Year Change
208.78%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.57B, an increase of 1,082.05%. That is a compound annual growth rate of 33.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.30B | 145.99% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |